A detailed history of Hantz Financial Services, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 16,234 shares of NVS stock, worth $1.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,234
Previous 15,986 1.55%
Holding current value
$1.6 Million
Previous $1.7 Million 9.69%
% of portfolio
0.03%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$106.13 - $120.89 $26,320 - $29,980
248 Added 1.55%
16,234 $1.87 Million
Q2 2024

Jul 30, 2024

BUY
$92.57 - $107.37 $1.48 Million - $1.72 Million
15,986 New
15,986 $1.7 Million
Q1 2024

Aug 06, 2024

SELL
$95.27 - $108.47 $37,345 - $42,520
-392 Reduced 1.58%
24,387 $2.36 Million
Q4 2023

Aug 06, 2024

SELL
$92.27 - $101.54 $120,227 - $132,306
-1,303 Reduced 5.0%
24,779 $2.5 Million
Q3 2023

Aug 06, 2024

SELL
$94.73 - $105.13 $424,579 - $471,192
-4,482 Reduced 14.66%
26,082 $2.66 Million
Q2 2023

Aug 06, 2024

BUY
$92.52 - $104.91 $112,689 - $127,780
1,218 Added 4.15%
30,564 $3.08 Million
Q1 2023

Aug 06, 2024

BUY
$80.03 - $92.81 $8,963 - $10,394
112 Added 0.38%
29,346 $2.7 Million
Q4 2022

Aug 06, 2024

SELL
$75.55 - $92.52 $144,527 - $176,990
-1,913 Reduced 6.14%
29,234 $2.65 Million
Q3 2022

Aug 06, 2024

BUY
$74.61 - $87.26 $62,448 - $73,036
837 Added 2.76%
31,147 $2.37 Million
Q2 2022

Aug 06, 2024

BUY
$80.52 - $93.75 $124,564 - $145,031
1,547 Added 5.38%
30,310 $2.56 Million
Q1 2022

Aug 06, 2024

BUY
$80.11 - $90.62 $281,266 - $318,166
3,511 Added 13.9%
28,763 $2.52 Million
Q4 2021

Aug 06, 2024

BUY
$79.7 - $88.13 $390,370 - $431,660
4,898 Added 24.06%
25,252 $2.21 Million
Q3 2021

Aug 06, 2024

BUY
$81.78 - $95.14 $301,849 - $351,161
3,691 Added 22.15%
20,354 $1.67 Million
Q2 2021

Aug 06, 2024

BUY
$85.24 - $94.15 $354,768 - $391,852
4,162 Added 33.29%
16,663 $1.52 Million
Q1 2021

Aug 06, 2024

SELL
$83.5 - $98.47 $290,997 - $343,167
-3,485 Reduced 21.8%
12,501 $1.07 Million
Q4 2020

Aug 06, 2024

SELL
$78.07 - $94.43 $164,571 - $199,058
-2,108 Reduced 61.39%
1,326 $125,000
Q3 2020

Aug 06, 2024

BUY
$82.14 - $91.0 $10,513 - $11,648
128 Added 3.87%
3,434 $299,000
Q2 2020

Aug 06, 2024

BUY
$80.93 - $91.1 $63,125 - $71,058
780 Added 30.88%
3,306 $289,000
Q1 2020

Aug 06, 2024

SELL
$70.67 - $99.01 $951,218 - $1.33 Million
-13,460 Reduced 84.2%
2,526 $208,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.